|
MIER3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.026300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.418620E-01 |
| Normal-vs-Stage2 |
4.578400E-01 |
| Normal-vs-Stage3 |
1.338140E-02 |
| Normal-vs-Stage4 |
2.321000E-03 |
| Stage1-vs-Stage2 |
9.794600E-01 |
| Stage1-vs-Stage3 |
1.134400E-01 |
| Stage1-vs-Stage4 |
3.012000E-02 |
| Stage2-vs-Stage3 |
4.075800E-01 |
| Stage2-vs-Stage4 |
2.580400E-01 |
| Stage3-vs-Stage4 |
6.075800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.940400E-02 |
| Normal-vs-AfricanAmerican |
5.381800E-04 |
| Normal-vs-Asian |
7.091200E-01 |
| Caucasian-vs-AfricanAmerican |
1.775570E-02 |
| Caucasian-vs-Asian |
7.773000E-01 |
| AfricanAmerican-vs-Asian |
2.161600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.065660E-02 |
| Normal-vs-Female |
1.451230E-01 |
| Male-vs-Female |
2.698400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.75290000000406E-05 |
| Normal-vs-Age(41-60Yrs) |
2.684300E-02 |
| Normal-vs-Age(61-80Yrs) |
9.016100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.882400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.376140E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.562600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.770500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.671800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.288800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.332200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.467800E-01 |
| Normal-vs-Grade 2 |
6.617600E-01 |
| Normal-vs-Grade 3 |
8.203300E-03 |
| Normal-vs-Grade 4 |
4.1233000003249E-07 |
| Grade 1-vs-Grade 2 |
7.644600E-01 |
| Grade 1-vs-Grade 3 |
5.190600E-01 |
| Grade 1-vs-Grade 4 |
1.290790E-01 |
| Grade 2-vs-Grade 3 |
1.016260E-02 |
| Grade 2-vs-Grade 4 |
2.89489999971693E-07 |
| Grade 3-vs-Grade 4 |
1.423520E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.252000E-01 |
| Normal-vs-ccB subtype |
3.956300E-04 |
| ccA subtype-vs-ccB subtype |
3.22210000014422E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.854200E-02 |
| Normal-vs-N1 |
3.539700E-03 |
| N0-vs-N1 |
1.196200E-01 |
|
|
